Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of Recombinant Human Erythropoietin (rhEPO) in Parkinson's Disease (PD)

NCT01010802 is registered in ClinicalTrials.gov with International Center for Neurological Restoration, Cuba as lead sponsor.

NCT NCT01010802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01010802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of Recombinant Human Erythropoietin (rhEPO) in Parkinson's Disease (PD)
Lead sponsor
International Center for Neurological Restoration, Cuba
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2008
Completion date
May 31, 2009
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease